Singular Genomics Systems Inc (OMIC)
0.4045
+0.02
(+4.01%)
USD |
NASDAQ |
Apr 19, 16:00
0.4045
0.00 (0.00%)
After-Hours: 20:00
Singular Genomics Systems Shareholders Equity (Quarterly): 179.01M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 179.01M |
| September 30, 2023 | 199.03M |
| June 30, 2023 | 218.39M |
| March 31, 2023 | 240.32M |
| December 31, 2022 | 260.32M |
| September 30, 2022 | 276.92M |
| June 30, 2022 | 297.56M |
| Date | Value |
|---|---|
| March 31, 2022 | 317.48M |
| December 31, 2021 | 336.17M |
| September 30, 2021 | 352.07M |
| June 30, 2021 | 366.58M |
| March 31, 2021 | -73.34M |
| December 31, 2020 | -51.56M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-73.34M
Minimum
Mar 2021
366.58M
Maximum
Jun 2021
224.54M
Average
260.32M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp | 1.377B |
| Azenta Inc | 2.444B |
| Harvard Bioscience Inc | 73.07M |
| Bionano Genomics Inc | 96.16M |
| Akoya Biosciences Inc | 53.77M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 265.47M |
| Total Liabilities (Quarterly) | 86.46M |
| Debt to Equity Ratio | 0.0497 |
| Current Ratio | 10.51 |
| Net Debt Paydown Yield | 0.72% |